This article refers to:
In the Drug Evaluation entitled “AICA-riboside (acadesine), an activator of AMP-activated protein kinase with potential for application in hematologic malignancies” by Eric Van Den Neste, Georges Van den Berghe & Francoise Bontemps, published in the April 2010 issue of Expert Opinion on Investigational Drug (Expert Opin. Investig. Drugs (2010) 19(4):571-578), it has been brought to our attention that the declaration of interest should have read as follows:
G Van den Berghe owns equity in Metabasis Therapeutics. The other authors declare no conflicts of interest.
The authors, editors and publisher sincerely regret any inconvenience this may have caused our readers.